Jump to content

Search the Community

Showing results for tags 'COVID-19 vaccine'.

  • Search By Tags

    Type tags separated by commas.
  • Search By Author

Content Type


Categories

  • Vaccine Safety Communication eLibrary

Find results in...

Find results that contain...


Date Created

  • Start

    End


Last Updated

  • Start

    End


Filter by number of...

Joined

  • Start

    End


Group


First name


Last name


Salutation


Country


Occupation


Organization


Website


I am joining because:

Found 24 results

  1. These questions and answers (Q&As) are based on the most recent interim recommendations from the WHO Strategic Advisory Group of Experts on Immunization (SAGE) for COVID-19 vaccines that have been approved by WHO under Emergency Use Listing (EUL)a as of 15 February 2022
  2. MVEC - The Road to a COVID-19 Vaccine is a resource including a video, allowing to explain how vaccines were developed and approved in Australia.
  3. The Vaccine Education Center at Children’s Hospital of Philadelphia is excited to announce the release of our second animation showing how COVID-19 vaccines work. This one shows how viral vector vaccines, such as the J&J and AZ vaccines, work. Weakened adenoviruses can be used to deliver a vaccine. In COVID-19 vaccines, instructions to make the SARS-CoV-2 spike protein are delivered to educate the immune system, preparing it for future encounters with SARS-CoV-2. Learn more: http://COVIDVaccineAnswers.org
  4. Resource including: factsheet for health workers job aid for COVID-19 vaccine administration quick guide
  5. Resources including: factsheet for health workers job aid for COVID-19 vaccine administration
  6. Resources including: interim recommendations for use of the AstraZeneca COVID-19 vaccine quick guide for vaccination factsheet for health workers job aid for COVID-19 vaccine administration
  7. The Hospital Clínico Universitario de Santiago, part of the Galician Healthcare System (SERGAS), was designated by the World Health Organization as a Collaborating Centre for Vaccine Safety in 2018. This is a great responsibility and a challenge, but one we can take on thanks to the excellence of the multidisciplinary clinical team at the Pediatrics Service of the Hospital Clínico Universitario de Santiago. Main objectives: To assist WHO in developing / updating training materials for health workers on vaccine safety, contraindications, and clinical management of adverse events following immunization. On request of WHO to provide support in conducting clinical AEFI investigations and AEFI crisis response. To contribute to WHO work in training of health workers on vaccine safety, contraindications, and introduction of new vaccines.
  8. Are the existing vaccines protective against all the COVID-19 variants of concern? Are the existing vaccines protective against all the COVID-19 variants of concern?
  9. Informations en français sur la sécurité des vaccins (Johnson & Johnson, Pfizer-BioNTech, Moderna) contre COVID-19.
  10. The HHS "We Can Do This" campaign is a national initiative working hand in hand with trusted leaders and community organizations to continue to build confidence in COVID-19 vaccines and get more people vaccinated. This campaign offers tailored resources and toolkits for stakeholders to use to provide COVID-19 vaccine information to at-risk populations.
  11. Join Doctor Mike Varshavski as he discusses how COVID-19 vaccines work on four levels understandable to a child, parent, student and vaccine expert.
  12. General Q & A for COVID-19 and related topics including: advices for adolescents and youth, breastfeeding, masks, children and masks. cleaning and disinfecting, climate, family planning, dexamethasone, food safety, hydroxychloroquine and others.
  13. This vaccine education PowerPoint deck is designed for use by public health officials to increase vaccine confidence in their communities. It includes areas that you can customize with local information and data. This template was requested on behalf of county and city health departments that have limited communications capacity and resources. It was published on Jan. 27, 2021, and you can make updates as vaccine development and distribution evolve.
  14. Information and guidance on a very rare condition involving blood clots and unusual bleeding after COVID-19 vaccination.
  15. List of questions regarding the temporary suspension of COVID-19 vaccine from AstraZeneca
  16. This playlist is part of a set of 52 COVID-19 FAQ explainer videos to answer the frequently asked questions about the types of vaccines including eligibility, safety, at-risk groups, rollout, intervals, common side effects, importance of two doses and who needs the vaccine and many more.
  17. In recognition of the critical importance of COVID-19 vaccines and the need to understand their safety, the CONSIDER (COvid-19 vacciNe Safety questIons anD hEalthcare pRoviders) working group (WG) was created in September 2020. The CONSIDER WG aims to provide clear, comprehensive answers to questions pertaining to COVID-19 vaccine safety prior to, and during the vaccines roll out to 1) facilitate scientific discussion between stakeholders, including front line health workers with potential vaccine recipients and 2) increase comprehension and transparency of information to facilitate acceptance and uptake.
  18. In episode 4 of our COVID-19 Road to a vaccine series, we spoke with Professor Kanta Subbarao. Professor Subbarao has been the Director of the World Health Organisation Collaborating Centre for Reference and Research on Influenza since 2016, based at The Doherty Institute at the University of Melbourne, Australia. In episode 5 of our COVID-19 Road to a vaccine series, we spoke with Professor Terry Nolan, who is a Redmond Barry Distinguished Professor at the Doherty Institute for Infection and Immunity. He heads up VIRGO, the vaccine and immunisation research group, a collaboration between Murdoch Children's Research Institute and the University of Melbourne. VIRGO has the largest and longest standing child and adolescent vaccine population research and clinical trials program in Australia.
  19. In Episode 2 of our podcast series 'COVID-19, Road to a Vaccine' we speak with Professor Kathryn Edwards from Vanderbilt University School of Medicine in Nashville, Tennessee, about the important topic of vaccine safety when developing a new vaccine, including some of the challenges faced in the COVID19 vaccine development pathway. In Episode 3, Associate Professor Nigel Crawford discusses the development of a COVID-19 vaccine with Professor Andrew Pollard, head of The Oxford Vaccine Group, who is co-leading The Oxford Vaccine Centre’s COVID-19 vaccine trial.
×
×
  • Create New...

Important Information

We have placed cookies on your device to help make this website better. You can adjust your cookie settings, otherwise we'll assume you're okay to continue. - Terms of Use - Privacy Policy - Guidelines